SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-000135
Filing Date
2023-01-03
Accepted
2023-01-03 09:38:35
Documents
1
Period of Report
2023-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2233798-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2233798-3_3seq1.xml 3 4085
  Complete submission text file 0001104659-23-000135.txt   5664
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Issuer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O QUOIN PHARMACEUTICALS, LTD. AZRIELI CENTER, ROUND TOWER, 30TH FLOOR TEL AVIV L3 6701101
Business Address
Culverwell Anthony James (Reporting) CIK: 0001693548 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37846 | Film No.: 23500566